Maintenance treatment prevents recurrence in older adults with single-episode depressions

March 15, 2006

People age 70 and older who continued taking the antidepressant that helped them to initially recover from their first episode of depression were 60 percent less likely to experience a new episode of depression over a two-year study period than those who stopped taking the medication, according to a study funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health. The study addresses a major question in the treatment of depression - when to discontinue medication.

Published today in the March 16, 2006 New England Journal of Medicine, the study showed that long-term treatment (for at least 2 years) after a patient is symptom-free is effective in preventing future depressive episodes.

"This study demonstrates the benefits of keeping older patients on an antidepressant long after they become symptom-free," said NIMH's director Thomas R. Insel, M.D.

The clinical trial tested whether maintenance therapy - long-term treatment given to patients to enable them to maintain a symptom-free or disease-free state - is effective in preventing future episodes of depression in patients 70 years and older. It also tested whether antidepressant medication and psychotherapy were effective, and whether the extent of patients' medical burden had an impact on rates of recurrence.

According to Charles F. Reynolds III, M.D., and colleagues at the University of Pittsburgh, the study speaks directly to the controversy over the benefits and risks of administering long-term antidepressant treatment to elderly patients who have only one lifetime occurrence of major depression. To date, the consensus has been that older patients experiencing their first episode of depression should be treated to full remission and then have a limited period of continuation treatment for 6 to 12 months to ensure the stability of the remission and further improve recovery.

"Most geriatric psychiatrists would not have thought that elderly 70 and older who experienced one episode of depression were candidates for longer term maintenance treatment of up to two years," said Reynolds. "They would agree that elderly with two or more episodes are appropriately prescribed maintenance treatment, but these data allow us to go one step further and suggest that, in fact, even those with single episodes fare considerably better out to two years if they continue use of the medication that got them well."

Patients ages 70 and older with depression who achieved full remission of symptoms after treatment using a combination of paroxetine (a selective serotonin reuptake inhibitor) and interpersonal psychotherapy (IPT) (psychotherapy that focuses on interpersonal relationships) were administered maintenance treatment where researchers tested the effectiveness of different treatment regimens in keeping patients symptom-free for up to 2 years. These patients were randomly assigned to one of four maintenance treatment groups: (1) paroxetine; (2) placebo; (3) paroxetine and monthly interpersonal psychotherapy (IPT); and (4) placebo and IPT.

The study found maintenance treatment was effective in older people with depression. Across all four treatment groups, rates of remission significantly differed. Among patients who received paroxetine in the maintenance phase, 63 percent remained in remission; 42 percent of those who received placebo remained in remission; 65 percent of patients who received paroxetine and IPT remained in remission; and 32 percent of patients who received placebo and IPT remained in remission.

Contrary to the researchers' hypothesis, which predicted that IPT would significantly reduce rates of recurrence, according to the study, IPT did not show preventive efficacy in people 70 years and older.

"But that does not mean that other types of psychotherapy are not effective," said Reynolds. "It could be that this population needs a more structured and focused type of psychotherapy - one that works better with cognitive impairment and greater disability than does IPT - such as problem-solving psychotherapy. Involving caregivers to a greater extent may also help."

The study also showed that older people with multiple chronic physical disorders did not do as well on paroxetine as those with fewer medical problems, although they did show some benefit. The burden associated with more chronic and disabling diseases often drives the depression, making it more difficult to treat, the authors conclude. Despite this, the researchers indicate that maintenance antidepressant medication may be effective in primary care settings where patients have multiple chronic diseases

"What makes this study so practical is that it shows you can combine chronic disease management of depression with the chronic disease management of other illnesses to benefit both the patient's mental illness as well as their physical illness," he said.

The study is part of an overall NIMH effort to conduct practical clinical trials in "real world" settings that address public health issues important to persons affected by major mental illnesses.
-end-
For more information on depression and how to treat it in older adults, visit http://www.nimh.nih.gov/healthinformation/depressionmenu.cfm and http://www.nimh.nih.gov/healthinformation/depoldermenu.cfm.

NIMH is part of the National Institutes of Health (NIH), the Federal Government's primary agency for biomedical and behavioral research. NIH is a component of the U.S. Department of Health and Human Services.

NIH/National Institute of Mental Health

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.